Considering the high expression level and critical regulation roles of DYRK2 in PCa, we took DYRK2 as a potential drug target and conducted a structure-based virtual screening of the Specs database and an in-house library to identify DYRK2 inhibitors (Fig. 3a, see Supplementary Methods for details). Here, DYRK2 is linked to posterior cortical atrophy.